Milbank, Tweed, Hadley & McCloy, LLP
Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
A method of diagnosing Alzheimer's disease in a patient comprises determining whether the phosphorylation level of an indicator protein in cells of the patient after stimulus with an activator compound is abnormally elevated as compared to a basal phosphorylation level, the indicator protein being e.g. Erk1/2 and the activator compound being e.g. bradykinin.
Blanchette Rockefeller Neurosciences Institute
G A A G G A A A G A G G
G01N A61K A61K G01N G01N A61K A61P A61P G01N A61K G01N G01N
additional inventional inventional additional additional inventional inventional inventional inventional inventional additional additional
Wei-Qin Daniel L.
Zhao Alkon